Part 1 Syncope and TLOC overview.
1 Definition and classification of syncope and transient.
loss of consciousness.
2 Epidemiologic aspects of transient loss of consciousness/syncope.
Robert S Sheldon, Anna Serletis.
3 Pathophysiology of syncope: postural, neurally-mediated,.
4 Cerebral perfusion in syncope.
J Gert van Dijk, Roland D Thijs.
5 Risk stratification—impact on diagnostic strategy.
Part 2 Clinical evaluation strategies.
6 Value and limitations of clinical history in assessing cause of syncope.
Paolo Alboni, Maurizio Dinelli.
7 Emergency department evaluation of transient loss of consciousness/.
Franc¸ois P Sarasin.
8 The essential autonomic assessment for evaluating the.
cause of syncope.
Carlos A Morillo, Juan C Guzman.
9 Neurally-mediated reflex syncope: recognition by history and.
Anna Serletis, Robert S Sheldon.
10 Value and limitations of ambulatory electrocardiographic monitoring.
Andrew D Krahn.
11 Recording ambulatory blood pressure in the syncope and.
12 Electrophysiologic testing: value and limitations in the transient loss of.
13 Intolerance to upright posture in autonomic failure and the postural.
tachycardia syndrome: assessment and treatment strategies.
Christopher J Mathias.
14 Improving tolerance to upright posture: current status of tilt-training.
and other physical maneuvers.
Hugo Ector, Tony Reybrouck.
15 Syncope in patients with bundle-branch block and other conduction.
Part 3 Specific conditions.
16 Treatment strategies in neurally-mediated reflex syncope: effectiveness of.
drugs, pacing, and physical maneuvers.
17 Structural heart disease, syncope, and risk of sudden death: selection of.
patients for implantable cardioverter-defibrillator therapy.
Kathy L Lee, Hung-Fat Tse, Chu-Pak Lau.
18 Channelopathies as a cause of syncope.
T Boussy, Pedro Brugada.
19 Distinguishing seizures and pseudosyncope from syncope.
Adam P Fitzpatrick.
20 Syncope and transient loss of consciousness in children and adolescents:.
congenital and acquired conditions.
21 Transient loss of consciousness, syncope, and falls in the elderly.
Rose Anne Kenny.
22 Drug-induced (iatrogenic) syncope.
Gerald V Naccarelli.
Part 4 Economic and research aspects.
23 Syncope and the competitive athlete: recommendations for evaluation.
and permission to compete.
Franco Giada, Antonio Raviele (Ospedale Umberto I).
24 Role of syncope management units.
Win K Shen, Michele Brignole (Ospedali del Tigullio).
25 The impact of syncope and transient loss of consciousness on.
quality of life.
Blair P Grubb.
Part 5 Current controversies and future directions.
26 Driving and flying restrictions for the syncope and/or implanted.
cardiac device patient.
Christina M Murray, Dwight W Reynolds.
27 Clinical trials landscape: what’s new, what’s ongoing, what do.
Michele Brignole (Ospedali del Tigullio), David G Benditt (University of Minnesota Medical School), Wouter Wieling (Academic Medical Centre).
28 Syncope and transient loss of consciousness: multidisciplinary.
A John Camm.
29 Syncope practice guidelines initiative.
David G Benditt (University of Minnesota Medical School).
Appendix: syncope consortium members.
● Takes the next step toward developing multidisciplinary practice guidelines for managing the broad variety of conditions associated with transient loss of consciousness (TLOC), including syncope
● Expert contributors address specific aspects of the current ESC Guidelines to give clear evaluations of suggested changes
● Draws on published literature and the authors professional experience